MENU

RAPP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Rapport Therapeutics (RAPP) Ownership - Who owns Rapport Therapeutics?

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

1.84B

P/E Ratio

21.81

Total Cash

476.78M

Projected Growth

N/A

Total Debt

10.8M

Revenue

20M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

9.97

Total Debt/Equity

N/A

Revenue/Share

0.48 USD as % of share price

View a ticker or compare two or three

VS

VS

RAPP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for RAPP

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details